• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MDXG

MDXG

MiMedx Group, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.61

+0.04 (+1.12%)

Rating:A

Company Profile

CEO

Joseph H. Capper

IPO Date

2008-02-12

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.56

Prev. Close

$3.57

Day Low

$3.50

Day High

$3.62

52W Low

$3.03

52W High

$7.99

Market Cap

$0.54B

Volume

1.28M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

24.1%

Avg Negative

2.8%

Avg Neutral

72.9%

News Feed

NAACP to Present Historic Spingarn Medal to Regenerative Engineering Pioneer Cato T. Laurencin, M.D.

GlobeNewsWire·7/14/2021·↑ positive

MIMEDX to Present at the Raymond James 2021 Human Health Innovation Conference

GlobeNewsWire·6/16/2021·↑ positive

New Study Demonstrates Potential for MIMEDX Purion® Processed Dehydrated Human Amnion/Chorion Membrane to Modulate Pathological Scar Tissue Formation

GlobeNewsWire·6/15/2021·↑ positive

MIMEDX to Participate at the Jefferies Virtual Healthcare Conference

GlobeNewsWire·5/27/2021·↑ positive

MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of Shareholders

GlobeNewsWire·5/25/2021·↓ negative

MIMEDX Urges Shareholders to Consider Prescience Point's Motivations Before Voting Their Shares at the Company's Annual Meeting

GlobeNewsWire·5/4/2021·↓ negative

MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders

GlobeNewsWire·5/3/2021·↑ positive

MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·4/29/2021·↓ negative

MiMedx Announces First Quarter 2021 Financial and Operating Results

GlobeNewsWire·4/28/2021·↑ positive

MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice President, Quality Assurance and Regulatory Affairs

GlobeNewsWire·4/28/2021·↑ positive